Lab
Iowa Physicians Clinic Medical Foundation
Iowa Physicians Clinic Medical Foundation was paid $828K by Medicaid between Jan 2018 and Sep 2022, across 63 billing codes. Its largest line is 80050, General health panel — 11% of everything it billed.
33Billing provider infoIOWA PHYSICIANS CLINIC MEDICAL FOUNDATION
FORT DODGE, IA 50501
FORT DODGE, IA 50501
33aNPI1164976437assigned 08/04/2016
33bProvider typeClinical Medical Laboratory
28Total paid$828K
24GClaims80,913
24DCodes billed63
24AFirst – last monthJan 2018 – Sep 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in Iowa
Rank by total paid#12 of 35
Median peer was paid$42K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,486 | $224K | |
| 2019 | 19,348 | $179K | |
| 2020 | 14,339 | $128K | |
| 2021 | 14,740 | $189K | |
| 2022 | 12,000 | $108K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80050 | General health panel | 11% | 2,148 | 1,975 | $95K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 5.5% | 113 | 109 | $45K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.3% | 6,402 | 6,040 | $44K |
| 80053 | Comprehensive metabolic panel | 5.2% | 4,713 | 4,468 | $43K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.9% | 94 | 83 | $40K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.7% | 2,864 | 2,697 | $39K |
| 87660 | 4.4% | 1,854 | 1,742 | $37K | |
| 87480 | 4.4% | 1,854 | 1,741 | $36K | |
| 87510 | 4.4% | 1,853 | 1,741 | $36K | |
| 80061 | Lipid panel | 4.3% | 3,213 | 3,081 | $36K |
| 87507 | 3.4% | 73 | 67 | $28K | |
| 36415 | Collection of venous blood by venipuncture | 3.3% | 11,183 | 10,050 | $27K |
51 more codes
| 86703 | 2.8% | 2,221 | $24K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.7% | 3,214 | $22K |
| 87653 | 2.4% | 659 | $20K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.4% | 2,555 | $20K |
| 84702 | 2.3% | 1,645 | $19K | |
| 84439 | 2.0% | 2,229 | $17K | |
| 84703 | 2.0% | 2,233 | $17K | |
| 87070 | 1.9% | 1,700 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.8% | 2,142 | $15K |
| 86762 | 1.6% | 1,278 | $13K | |
| 86850 | 1.4% | 1,779 | $11K | |
| 87186 | 1.2% | 1,222 | $10K | |
| 85027 | 1.1% | 1,670 | $9K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 102 | $8K |
| 87088 | <1% | 932 | $7K | |
| 83550 | <1% | 856 | $6K | |
| 80069 | <1% | 878 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 183 | $6K |
| 86140 | <1% | 1,182 | $6K | |
| 82728 | <1% | 487 | $5K | |
| 83540 | <1% | 914 | $5K | |
| 82947 | <1% | 1,657 | $5K | |
| 81001 | <1% | 1,636 | $4K | |
| 82950 | <1% | 978 | $4K | |
| 87081 | <1% | 542 | $4K | |
| 86900 | <1% | 1,654 | $4K | |
| 86901 | <1% | 1,650 | $3K | |
| 85018 | <1% | 1,517 | $3K | |
| 87581 | <1% | 94 | $3K | |
| 87486 | <1% | 94 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 93 | $3K |
| 82043 | <1% | 708 | $3K | |
| 82570 | <1% | 756 | $3K | |
| 85014 | <1% | 1,183 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 15 | $2K |
| 87205 | <1% | 473 | $2K | |
| 87077 | <1% | 162 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $1K |
| 83735 | <1% | 196 | $1K | |
| 85652 | <1% | 420 | $1K | |
| 84153 | <1% | 57 | $911.05 | |
| 83690 | <1% | 116 | $739.37 | |
| 80076 | <1% | 87 | $604.07 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 15 | $447.44 |
| 83880 | <1% | 15 | $415.56 | |
| 85610 | <1% | 167 | $326.39 | |
| 84460 | <1% | 75 | $322.57 | |
| 82150 | <1% | 28 | $169.32 | |
| 82247 | <1% | 39 | $166.69 | |
| 82565 | <1% | 15 | $44.51 | |
| 3044F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, DAVID (PRESIDENT/CEO)
Parent organizationIOWA PHYSICIANS CLINIC MEDICAL FOUNDATION
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.